Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by University of Texas at Austin, College of Natural Sciences, and Marc Airhart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by University of Texas at Austin, College of Natural Sciences, and Marc Airhart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Score to Settle with Cancer

13:20
 
Share
 

Manage episode 199202096 series 1118522
Content provided by University of Texas at Austin, College of Natural Sciences, and Marc Airhart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by University of Texas at Austin, College of Natural Sciences, and Marc Airhart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Jonathan Sessler was a college student when he was first diagnosed with Hodgkin’s lymphoma. Fortunately, he was also a chemistry major. After surviving radiation therapy, relapsing and then surviving extremely high doses of what he calls “rat poison” (a.k.a. chemotherapy), his oncologist challenged him: “You’re a chemist. Find new cancer drugs.”

In the four decades since, he’s founded two companies, one of which commercialized a blockbuster drug for leukemia and was sold for $21 billion. The other is working to develop a drug he invented to treat ovarian cancer, based on large molecules that deliver poisons to cancer cells and named after the Lone Star state: Texaphyrin. He knows the odds of bringing effective new cancer treatments to market are stacked against him, yet he tirelessly pushes ahead.

Last month, he spoke to producer Marc Airhart in front of a live audience at the annual meeting of the American Association for the Advancement of Science.

About Point of Discovery

Point of Discovery is a production of the University of Texas at Austin's College of Natural Sciences. You can listen to all our episodes at @point-of-discovery .

You can also subscribe via iTunes: https://itunes.apple.com/us/podcast/point-of-discovery-podcast/id1036884430?mt=2
or via our RSS feed: http://feeds.soundcloud.com/users/soundcloud:users:150441582/sounds.rss
or via Stitcher: www.stitcher.com/podcast/point-of-discovery
or via Google Play: https://play.google.com/music/m/Igc5ifenl2bn7e5n2klmrwah7qq?t=Point_of_Discovery

Questions or comments about this episode, or our series in general? Email Marc Airhart at mairhart[AT]austin.utexas.edu

About Point of Discovery

Point of Discovery is a production of the University of Texas at Austin's College of Natural Sciences and is a part of the Texas Podcast Network. The opinions expressed in this podcast represent the views of the hosts and guests, and not of The University of Texas at Austin. You can listen via Apple Podcasts, Spotify, RSS, Amazon Podcasts, and more. Questions or comments about this episode or our series in general? Email Marc Airhart.

  continue reading

62 episodes

Artwork

A Score to Settle with Cancer

Point of Discovery

16 subscribers

published

iconShare
 
Manage episode 199202096 series 1118522
Content provided by University of Texas at Austin, College of Natural Sciences, and Marc Airhart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by University of Texas at Austin, College of Natural Sciences, and Marc Airhart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Jonathan Sessler was a college student when he was first diagnosed with Hodgkin’s lymphoma. Fortunately, he was also a chemistry major. After surviving radiation therapy, relapsing and then surviving extremely high doses of what he calls “rat poison” (a.k.a. chemotherapy), his oncologist challenged him: “You’re a chemist. Find new cancer drugs.”

In the four decades since, he’s founded two companies, one of which commercialized a blockbuster drug for leukemia and was sold for $21 billion. The other is working to develop a drug he invented to treat ovarian cancer, based on large molecules that deliver poisons to cancer cells and named after the Lone Star state: Texaphyrin. He knows the odds of bringing effective new cancer treatments to market are stacked against him, yet he tirelessly pushes ahead.

Last month, he spoke to producer Marc Airhart in front of a live audience at the annual meeting of the American Association for the Advancement of Science.

About Point of Discovery

Point of Discovery is a production of the University of Texas at Austin's College of Natural Sciences. You can listen to all our episodes at @point-of-discovery .

You can also subscribe via iTunes: https://itunes.apple.com/us/podcast/point-of-discovery-podcast/id1036884430?mt=2
or via our RSS feed: http://feeds.soundcloud.com/users/soundcloud:users:150441582/sounds.rss
or via Stitcher: www.stitcher.com/podcast/point-of-discovery
or via Google Play: https://play.google.com/music/m/Igc5ifenl2bn7e5n2klmrwah7qq?t=Point_of_Discovery

Questions or comments about this episode, or our series in general? Email Marc Airhart at mairhart[AT]austin.utexas.edu

About Point of Discovery

Point of Discovery is a production of the University of Texas at Austin's College of Natural Sciences and is a part of the Texas Podcast Network. The opinions expressed in this podcast represent the views of the hosts and guests, and not of The University of Texas at Austin. You can listen via Apple Podcasts, Spotify, RSS, Amazon Podcasts, and more. Questions or comments about this episode or our series in general? Email Marc Airhart.

  continue reading

62 episodes

Alla avsnitt

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play